InvestorsHub Logo
Followers 4
Posts 1270
Boards Moderated 0
Alias Born 05/17/2012

Re: None

Sunday, 01/08/2017 12:23:41 PM

Sunday, January 08, 2017 12:23:41 PM

Post# of 14944
We are currently selling several opioid products. For good reason, the industry is being pressured to convert to abuse deterrent products. This could be the reason for the molecular biologist position.

http://blogs.fda.gov/fdavoice/index.php/2016/10/key-facts-about-abuse-deterrent-opioids
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ANIP News